NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 65862-0859-01 — famotidine 20 mg tabletAI (349 hospitals, 27,599–28,373 samples)
• NDC 25021-0114-87 — Ciprofloxacin IV infusion in dextrose solutionAI (917 hospitals, 26,567–28,358 samples)
• NDC 00409-3182-31 — Lidocaine 2% with epinephrine injectionAI (95 hospitals, 26,713–28,342 samples)
• NDC 67877-0319-01 — ibuprofen 400 mg tabletAI (363 hospitals, 27,550–28,324 samples)
• NDC 63739-0665-10 — QUETIAPINE 100 MG TABLETAI (192 hospitals, 27,777–28,317 samples)
• NDC 00904-6449-61 — Isosorbide mononitrate 30 mg extended-release tabletsAI (801 hospitals, 27,613–28,315 samples)
• NDC 63323-0201-02 — Lidocaine 1% injectable solutionAI (514 hospitals, 25,281–28,314 samples)
• NDC 60687-0677-01 — Allopurinol 100 mg tabletsAI (396 hospitals, 27,700–28,312 samples)
• NDC 69374-0919-10 — Succinylcholine chloride injection, 200 mg per 10 mL syringeAI (390 hospitals, 26,005–28,309 samples)
• NDC 51079-0734-20 — Haloperidol 1 mg tablets, blister pack of 100AI (720 hospitals, 27,656–28,304 samples)
• NDC 70069-0747-25 — Potassium phosphate intravenous solutionAI (242 hospitals, 27,287–28,304 samples)
• NDC 51079-0821-20 — Levetiracetam 500 mg tabletsAI (499 hospitals, 27,611–28,304 samples)
• NDC 71288-0714-11 — Cisatracurium IV muscle relaxant injection, 20 mg per 10 mLAI (277 hospitals, 27,133–28,303 samples)
• NDC 63323-0464-38 — Sensorcaine-MPF 0.25% injection solutionAI (144 hospitals, 26,725–28,291 samples)
• NDC 60687-0437-01 — Amiodarone 200 mg tabletsAI (519 hospitals, 27,543–28,290 samples)
• NDC 00185-0055-01 — metOLazone 5 mg tabletAI (501 hospitals, 27,630–28,287 samples)
• NDC 68462-0292-01 — Verapamil extended-release 120 mg tabletsAI (864 hospitals, 27,673–28,285 samples)
• NDC 51079-0074-20 — Hydralazine 10 mg oral tabletsAI (547 hospitals, 27,609–28,284 samples)
• NDC 00517-1004-25 — Atropine sulfate injection 0.4 mg/mLAI (671 hospitals, 27,167–28,265 samples)
• NDC 63323-0487-03 — Lidocaine with epinephrine local anesthetic injectionAI (104 hospitals, 26,705–28,262 samples)
• NDC 75907-0024-11 — Clonidine 0.2 mg weekly transdermal patchAI (280 hospitals, 27,208–28,261 samples)
• NDC 00264-5802-00 — Sodium chloride 0.9% intravenous solutionAI (217 hospitals, 24,891–28,257 samples)
• NDC 70860-0405-41 — Bumetanide 0.25 mg/mL injectionAI (276 hospitals, 25,676–28,250 samples)
• NDC 00781-1486-01 — AMITRIPTYLINE 10 MG TABLETAI (211 hospitals, 27,644–28,247 samples)
• NDC 00591-0900-30 — Glipizide extended-release 2.5 mg tabletAI (201 hospitals, 27,644–28,247 samples)
• NDC 68462-0137-01 — OXCARBAZEPINE 150 MG TABLETAI (368 hospitals, 27,624–28,245 samples)
• NDC 63323-0093-01 — Concentrated sodium chloride injection, 30 mL vialAI (699 hospitals, 27,179–28,241 samples)
• NDC 68084-0823-21 — Methylphenidate 10 mg oral tabletsAI (427 hospitals, 27,650–28,235 samples)
• NDC 00781-1831-20 — Amoxicillin-clavulanate 500/125 mg tabletAI (222 hospitals, 27,618–28,230 samples)
• NDC 00904-7083-61 — Ciprofloxacin 500 mg tabletsAI (344 hospitals, 27,448–28,222 samples)
• NDC 55150-0202-00 — Pantoprazole 40 mg IV injectionAI (577 hospitals, 26,447–28,220 samples)
• NDC 50268-0684-15 — Prochlorperazine maleate 5 mg tabletsAI (516 hospitals, 27,162–28,215 samples)
• NDC 81033-0025-05 — Lidocaine-prilocaine numbing creamAI (130 hospitals, 27,144–28,215 samples)
• NDC 60505-0253-02 — CLOPIDOGREL 75 MG TABLETAI (162 hospitals, 27,602–28,214 samples)
• NDC 60687-0433-01 — Amitriptyline 25 mg tabletsAI (596 hospitals, 27,535–28,210 samples)
• NDC 00904-6868-61 — Trazodone 50 mg tabletsAI (770 hospitals, 27,646–28,204 samples)
• NDC 00591-0343-01 — Verapamil 80 mg oral tabletsAI (371 hospitals, 27,600–28,194 samples)
• NDC 00143-9526-10 — Dexmedetomidine in saline IV solutionAI (117 hospitals, 27,042–28,194 samples)
• NDC 81964-0221-14 — Amoxicillin-clavulanate 875/125 mg tabletAI (247 hospitals, 27,602–28,187 samples)
• NDC 65862-0006-01 — Citalopram 20 mg tablets, bottle of 100AI (212 hospitals, 27,602–28,187 samples)
• NDC 57237-0030-01 — Amoxicillin 250 mg capsulesAI (232 hospitals, 27,599–28,184 samples)
• NDC 50268-0604-15 — Nortriptyline 25 mg capsulesAI (310 hospitals, 27,580–28,183 samples)
• NDC 51672-4069-01 — Phenytoin oral suspension 125 mg per 5 mLAI (469 hospitals, 27,580–28,183 samples)
• NDC 60687-0468-01 — IBUPROFEN 800 MG TABLETAI (195 hospitals, 27,580–28,183 samples)
• NDC 62584-0734-01 — HYDRALAZINE 50 MG TABLETAI (227 hospitals, 27,580–28,183 samples)
• NDC 00143-9982-01 — Amoxicillin-clavulanate oral liquid antibioticAI (248 hospitals, 27,489–28,182 samples)
• NDC 50268-0398-50 — Hydroxyzine pamoate 25 mg capsulesAI (176 hospitals, 27,579–28,173 samples)
• NDC 68094-0063-62 — Megestrol acetate oral liquid, unit doseAI (263 hospitals, 27,579–28,173 samples)
• NDC 00409-1966-05 — Bacteriostatic sodium chloride 0.9% injectionAI (151 hospitals, 27,905–28,166 samples)
• NDC 65162-0101-10 — Gabapentin 100 mg oral capsulesAI (259 hospitals, 27,597–28,164 samples)